BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5659425)

  • 1. MSH activity in the rat pituitary after treatment with Nembutal and morphine: a new bioassay for MSH-release inhibiting factor (MIF).
    Kastin AJ; miller MC; Schally AV
    Endocrinology; 1968 Jul; 83(1):137-40. PubMed ID: 5659425
    [No Abstract]   [Full Text] [Related]  

  • 2. MSH activity in plasma and pituitaries of rats after various treatments.
    Kastin AJ; Schally AV; Viosca S; Miller MC
    Endocrinology; 1969 Jan; 84(1):20-7. PubMed ID: 4881999
    [No Abstract]   [Full Text] [Related]  

  • 3. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
    Vivas A; Celis ME
    Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I.
    Kastin AJ; Schally AV; Kostrzewa RM
    Fed Proc; 1980 Sep; 39(11):2931-6. PubMed ID: 6105977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the release of melanocyte-stimulating hormone in vitro by rat pituitary glands collected at various times during the oestrous cycle.
    Vivas A; Celis ME
    J Endocrinol; 1978 Jul; 78(1):1-6. PubMed ID: 567239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional evidence for dissociation of melanocyte-stimulating hormone and corticotrophin release.
    Dunn JD; Kastin AJ; Carrillo AJ; Schally AV
    J Endocrinol; 1972 Nov; 55(2):463-4. PubMed ID: 4344237
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of stimulating effect of hypertonic Nacl intravenous injection on the release of melanocyte-stimulating hormone from the hypothalamic end of the cut pituitary stalk.
    Cyrkowicz A; Traczyk W
    Acta Physiol Pol; 1976; 27(1):101-3. PubMed ID: 1274596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical activity from cells in the whole, isolated, intact bovine pituitary gland. II. Changes induced by injection of pentobarbital and morphine.
    Boyd WH
    Endocrinol Exp; 1984 Mar; 18(1):31-4. PubMed ID: 6609065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of melanocyte-stimulating hormone (MSH) from incubated in situ posterior pituitary lobe in rats.
    Cyrkowicz A; Traczyk WZ
    Bull Acad Pol Sci Biol; 1972; 20(5):357-60. PubMed ID: 4537645
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of melanophore stimulating hormone (MSH) release.
    Hadley ME; Bower A; Hruby VJ
    Yale J Biol Med; 1973 Dec; 46(5):602-16. PubMed ID: 4544339
    [No Abstract]   [Full Text] [Related]  

  • 11. Action potentials in rat and lizard pars intermedia cells: inhibition by dopamine and stimulation by 5-hydroxytryptamine, two suspected regulators of MSH secretion [proceedings].
    Douglas WW; Taraskevich PS
    J Physiol; 1978 Jul; 280():13P. PubMed ID: 690858
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation and structure of another hypothalamic peptide possessing MSH-release-inhibiting activity.
    Nair RM; Kastin AJ; Schally AV
    Biochem Biophys Res Commun; 1972 Jun; 47(6):1420-5. PubMed ID: 5040241
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of the nervous system upon adrenal gland weight and assayable pituitary MSH.
    Francis MG; Barnawell EB
    Neuroendocrinology; 1978; 27(5-6):228-38. PubMed ID: 153481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanophore stimulating hormone (MSH) release: inhibition by cytochalasin B and "stimulation" by dimethyl sulfoxide.
    Bower SA; Hadley ME
    Endocrinology; 1975 Feb; 96(2):431-9. PubMed ID: 1078655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against mass action direct feedback control of melanophore-stimulating hormone (MSH) release.
    Huntington T; Hadley ME
    Endocrinology; 1974 Aug; 95(2):472-9. PubMed ID: 4546804
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum melanocyte-stimulating hormone levels and pituitary melanocyte-stimulating hormone content during pseudopregnancy in the rat.
    Volosin M; Celis ME
    Endocrinology; 1979 Aug; 105(2):541-3. PubMed ID: 456328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal by vasotocin of pinealectomy and constant light effects on the pituitary melanocyte-stimulating hormone (MSH) content in the mouse.
    Pavel S; Gheorghiu C; Calb M; Petrescu M
    Endocrinology; 1975 Sep; 97(3):674-6. PubMed ID: 1175514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone.
    Celis ME; Taleisnik S; Walter R
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1428-33. PubMed ID: 5283931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms that determine the changes in pituitary MSH activity during pseudopregnancy induced by vaginal stimulation in the rat.
    Taleisnik S; Tomatis ME
    Neuroendocrinology; 1970; 6(5):368-77. PubMed ID: 5482112
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonistic effect on melanocyte-stimulating hormone release of two neural tissue extracts.
    Taleisnik S; Tomatis ME
    Am J Physiol; 1967 Jan; 212(1):157-63. PubMed ID: 4289089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.